CCL13 and rheumatoid arthritis: Notably, combined blockade of MCP1 and MCP4 failed to synergistically inhibit monocyte recruitment in RA synovium, possibly because CCL13 and CCL2 jointly use the chemokine receptor CCR2 on monocytes, and thus, CCL13 blockade was as effective as CCL2 (29).